ABOUT - GIIEvent · Keynote Helmy Eltoukhy Guardant Health Session: Isolation, Characterization, &...
Transcript of ABOUT - GIIEvent · Keynote Helmy Eltoukhy Guardant Health Session: Isolation, Characterization, &...
ABOUT
Our conferences are designed with our sponsors and exhibitors in mind: we create intimate and highly interactive environments so that they can maximize their reach and make long-lasting contacts. Our sponsors and exhibitors benefit from a few of the following:
• Sponsors/exhibitors have the option to receive the delegate list a week before and a week after the conference.
• The exhibit space for the meeting is shared with any other concurrent conferences, providing sponsors and exhibitors with access to a larger audience. The exhibit space is also where all networking functions take place, including coffee, snack stations, breakfast, and the evening reception.
• Your corporate logo will be placed on the cover page of the conference brochures, the proceedings given to all conference delegates, and on the presentation screen during all breaks to enhance your company’s visibility at the event. Your logo will also be placed on the conference website agenda linked to your website.
SPONSORSHIP OPPORTUNITIES
We invite you to attend the Molecular Diagnostics Summit, which takes place July 6 - 8, 2016 in Boston, MA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below:
2nd Cancer Markers & Liquid Biopsies (Jul 6-7) - The role of cancer markers is significant towards the diagnosis, prognosis, and surveillance of a patient. Understanding markers and characterizing circulating elements with the latest technologies aid our progress toward the future of better personalized cancer care. Leaders in industry and academia will discuss platforms for iso-lating and studying CTCs. This meeting will also discuss biomarker sensitivity, stability, validation, and how we can use markers to follow up with patients and improve the quality of life.
Digital PCR & qPCR (Jul 6-7) -There has been a push to find a faster and a more efficient way to optimize the quantification of nucleic acids. In the past, quantitative polymerase chain reaction (qPCR) has been the best way to measure the relative ampli-fication of PCR in real time. In more recent years, digital PCR has become a newer method of PCR quantification that can result in absolute quantification, increased sensitivity in samples, more controllable precision, and multiple partitions of the same sample. This meeting will discuss the newest developments in digital PCR and qPCR in relation to how PCR can be used the molecular diagnostics field.
Precision Medicine (Jul 7-8) - There is a huge drive in Precision Medicine as it integrates research and clinical practice to build a knowledge base that can better guide individualized patient care. At a crucial time, where there are efforts to scale up population-based genome sequencing and integrate it with clinical data, this meeting will discuss the progress towards the implementation of precision medicine. This conference will discuss the future of healthcare, strategies and technologies for successful implementation, precision medicine beyond oncology, integrating and interpreting personal genomics, big data, bioinformatics, and overcoming challenges in the commercialization of precision medicine.
If you are interested in participating in the Summit’s poster session to showcase your work and research, please submit an abstract here and select which conference you would like to present in by June 6, 2016. In addition, the top two to three abstracts submitted for each individual conference will be selected to give a short oral presentation as part of that conference’s program. Presentation slots fill up fast so please submit your abstract ASAP.
POSTER & ORAL PRESENTATION OPPORTUNITIES
For sponsorship and exhibit opportunities, please contact:Amber Kempf
Senior Account [email protected]
Nicolas RodriguezAccount Executive
SPONSORS
GOLD
CORPORATE
Viracor-IBT is a CAP/CLIA accredited laboratory providing large molecule biomarker support for phase I-IV trials. Viracor-IBT has 30+ years of experience in molecular testing, immune response monitoring, allergy/hypersensitivity testing. Expertise includes custom assay design, optimization, transfer and validation. Our streamlined processes provide more options and flexibility for your specific needs.
PGDx advances the frontiers of cancer medicine through innovative genomic technologies for oncology researchers, drug developers, clinicians and patients. PGDx is working toward broad patient access, through both CLIA-certified facility providing comprehensive genomic services, and a technology transfer solution enabling molecular laboratories to easily internalize testing. Co-founders Luis Diaz, MD, and Victor Velculescu, MD, PhD, are recognized leaders in cancer genomics with extensive experience in advanced genomic technologies to research, drug development and clinical practice.
Using novel epigenetic technology, Epiontis provides precise and reproducible immunomonitoring services for clinical trials. The epigenetic PCR tests are based on in-house developed and IP protected markers specific for immune cell types (Treg, Th17, overall Tcells, etc.). Frozen whole blood or tissue can be used, permitting easy storage and logistics.
MEDIA PARTNERS
Foundation Medicine (NASDAQ:FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company’s clinical assays, FoundationOne® for solid tumors and FoundationOne® Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
Keynote
Helmy Eltoukhy Guardant Health
Session:Isolation, Characterization, & Diagnostic applications of
CTCs
Session:Isolation, Characterization, & Diagnostic applications of
CTCs (cont.)
Session:Advances in the Clinical Application of Circulating Nucleic
Acid
Session:Validation & Application of Cancer Specific Markers
Session:Current Progress in Exosome Applications
Session: Clinical & Biological Challenges in Liquid Biopsy
Session:Novel Uses of Digital PCR
Session:Data Analysis and Reproducible Research
Session:Validation & Standardization: Optimization of PCR
Session:Detection & Quantification of Nucleic Acids
Session:qPCR in Diagnostics
Session:qPCR in Diagnostics
AGENDA AT-A-GLANCE
Day 1 - Wednesday, July 6, 2016
7:007:55
8:00
10:00
10:30
12:10
1:10
3:15
3:45
6:15
7:00
8:00
10:00
10:35
1:00
Registration & Continental BreakfastWelcome & Opening Remarks
Digital PCR & qPCR2nd Cancer Markers & Liquid Biopsies
Day 2 - Thursday, July 7, 2016
Continental Breakfast
All times are approximate and subject to changes without notice
Morning Networking Break
Morning Networking Break
Lunch Provided by GTCbio
Afternoon Networking Break
Evening Reception & Poster Session
Digital PCR & qPCR2nd Cancer Markers & Liquid Biopsies
Conferences Conclude
Session:Overcoming Challenges in the Commercialization of Precision Medicine
Session: Implementation of Precision Medicine: Strategies & Technologies
Session: Implementation of Precision Medicine: Strategies & Technologies
Session:Precision Medicine Beyond Oncology
Session:Integrating & Interpreting Personal Genomics, Big Data, & Bioinformatics
Session:Incentivizing Precision Medicine: Regulation & Reimbursement
AGENDA AT-A-GLANCE
Day 2 - Thursday, July 7, 2016
1:00
2:00
4:05
4:35
5:55
7:00
8:00
10:00
10:40
11:55
1:00
3:05
3:35
5:15
Registration
Precision Medicine
Day 3 - Friday, July 8, 2016
Continental Breakfast
All times are approximate and subject to changes without notice
Afternoon Networking Break
Evening Reception & Poster Session
Morning Networking Break
Precision Medicine
Lunch Provided by GTCbio
Conferences Conclude
Afternoon Networking Break
Farideh BischoffSilicon Biosystems
Agnieszka BroniszBrigham and Women’s Hospital
Carlos Cordon-CardoMount Sinai School of Medicine
Z Hugh FanUniversity of Florida
Sandra GastonTufts Medical Center
Giulio GenoveseBroad Institute
Chwee Teck LimNational University of Singapore
Quan LuHarvard School of Public Health
Jun LuoJohns Hopkins Hospital
John MartignettiIcahn School of Medicine at Mount Sinai
Stuart MartinUniversity of Maryland
Irina Matei Weill-Cornell Medical College
For an updated speaker list visit: www.gtcbio.com/molecular/speakers
DISTINGUISHED SPEAKERSOvercoming the Challenges of Heterogeneous Liquid Biopsies Through Precise Image-based Single-cell Sorting
Extracellular Vesicles and Intra-tumoral Heterogeneity of Glioblastoma
CTC Isolation Methods and Clinical Applications
2nd Cancer Markers & Liquid Biopsies
Session: Clinical & Biological Challenges in Liquid Biopsy
Session: Validation & Application of Cancer Specific Markers
KEYNOTE SPEAKER
From Wired to Wireless: The Guardant Experience with 20,000+ Clinical Liquid Biopsies
Mechanism and Therapeutic Application of ARRDC1-mediated Microvesicles (ARMMs)
Session: Advances in the Clinical Application of Circulating Nucleic Acid
Novel Microfluidic Device to Rapidly Test Patient Tumor Cells for Cytoskeletal Drug Responses
Treatment Selection in Prostate Cancer: Exploring the Full Potential of Liquid Biopsies
Helmy EltoukhyGuardant Health
Clonal Expansions in Blood and the Risk of Hematological Malignancies
Tumor-derived Exosomes and Their Promise as Diagnostic and Predictive Biomarkers
Microfluidics for the Single Cell Analysis of Circulating Tumor Cells
Paraskevi GiannakakouWeill-Cornell Medical College
Michael HellerUniversity of California San Diego
Chris KarlovichClovis Oncology
Roya Khosravi-FarBeth Israel Deaconess Medical Center
Keith KnutsonMayo Clinic
Rebecca LearyNovartis Institutes for Biomedical Research
Towia LibermannBeth Israel Deaconess Medical Center
Johan Skog Exosome Diagnostics
Sherilyn SawyerBrigham and Women’s Hospital
Phil StephensFoundation Medicine
Bakhos TannousMassachusetts General Hospital
Yaoyu WangDana-Farber Cancer Institute
Robert WeinbergMassachusetts Institute of Technology
Yong ZengUniversity of Kansas
For an updated speaker list visit: www.gtcbio.com/molecular/speakers
DISTINGUISHED SPEAKERSDrug-Target Engagement in CTCs: From Mechanism to Clinical Application in Prostate Cancer
Rapid Isolation and Detection of Circulating Cell Free DNA, RNA and Exosome Biomarkers for Liquid Biopsy Cancer Diagnostics
Early Detection of Pancreatic Cancer Using a New 5-gene Classifier
2nd Cancer Markers & Liquid Biopsies
Soluble Innate and Adaptive Immune System Mediators as Biomarkers for Diagnosis, Prognosis and Response to Therapy in Cancer
Molecular Assessment of Biofluid Biopsies from NSCLC Patients Treated with Rociletinib
Session: Current Progress in Exosome Applications
Session: Clinical & Biological Challenges in Liquid Biopsy
Tumor-Educated Platelets: A Novel Platform for Blood-Based Pan-Cancer, Multi Class and Molecular Pathway Cancer Diagnostics
Challenges of ctDNA Diagnostics for Patients with Cancer
Characterizing the Cancer Genome from the Circulation
Standardizing Extracellular Small RNASeq for Biomarker Discovery
Session: Advances in the Clinical Application of Circulating Nucleic Acid
Mechanisms of Malignant Progression of Carcinomas
Microfluidic Analysis of Circulating Exosomes Toward Non-Invasive Cancer Diagnosis
Ramana DavuluriNorthwestern University - Feinberg School of Medicine
Jarrod DeanSanofi
Hatice DuzkaleChildren’s Hospital Medical Center
Manuela HofnerAIT Austrian Institute of Technology
Pierre Laurent-PuigDescartes University
Preveen RamamoorthyStrand Life Sciences
Kenneth PierceBrandeis University
Rashmi Kanagal ShamannaMD Anderson Cancer Center
Chen SongDana-Farber Cancer Institute, Harvard Medical School
Dejan StebihNational Institute of Biology
Jennifer TaylorRTI International
Joel TellinghuisenVanderbilt University
Alexander UrbanStanford University
James WilleyUniversity of Toledo College of Medicine
For an updated speaker list visit: www.gtcbio.com/molecular/speakers
DISTINGUISHED SPEAKERS
Session: Data Analysis and Reproducible Research
Applications of qPCR in Next-Gen Sequencing
Digital PCR & qPCR
Session: Novel Uses of Digital PCR
Development of Multi-Target ddPCR Methods for Detection of Genetically Modified Organisms
Session: qPCR in Diagnostics
Session: qPCR in Diagnostics
Session: Validation & Standardization: Optimization of PCR
Microfluidics-Based qPCR, a Versatile Tool for Biomarker Analysis: From MSRE-Based qPCR to High-Throughput Multiplex Immunoassay
Novel Mutation Enrichment Approaches for Increasing Sensitivity and Specificity of Molecular Diagnostics Assays
PCR Strategies for Identifying Multiple Bacterial Species Using a Closed-Tube Assay
Using Digital PCR in Newborn Screening to Characterize Calibrators and Reference Materials for Quantitative Molecular Assays
Using Least Squares to Design Better qPCR Analysis Protocols
Comparing Drop Digital PCR to Quantitative PCR: Evolving the Gene Therapy Viral Vector Analytical Paradigm
Session: Novel Uses of Digital PCR
Precision Medicine
Gil AlterovitzHarvard Medical School
Kristine Ashcraft Genelex
Keith F. BatchelderGenomic Healthcare Strategies
Thomas BrownSwedish Cancer Institute
Kenneth J BloomHuman Longevity
Pieter R. CullisUniversity of British Columbia
Martin DawesThe University of British Columbia
Hans LehrachMax Planck Institute for Molecular Genetics
Christine LuHarvard Medical School & Harvard Pilgrim Health Care Institute
John Mattison Kaiser Permanente
Jen MadsenArnold & Porter
Iain MillerHealthcare Strategies Group; NICE; European Personalized Medicine Association
Liz MilwardThe University of Newcastle Australia
Ken RamosArizona Health Sciences Center
DISTINGUISHED SPEAKERS
Pharmacogenetic Testing and Medication Decision Support in Primary Care
Regulation & Reimbursement: Access to Precision Medicine Products
The Federal Government Innovates, Too: Changes in the Regulatory & Reimbursement Framework
Session: Incentivizing Precision Medicine: Regulation & Reimbursement
Session: Integrating & Interpreting Personal Genomics, Big Data, & Informatics
Session: Integrating & Interpreting Personal Genomics, Big Data, & Informatics
Bringing Diagnostics to Market
Introducing Molecular Medicine into the Population: The Personalized Medicine Initiative
Session: Integrating & Interpreting Personal Genomics, Big Data, & Informatics
For an updated speaker list visit: www.gtcbio.com/molecular/speakers
The Future of Translational and Clinical Genomics in Precision Medicine
The Emerging Commercial Paradigm for Precision Medicine and Companion Diagnostics: Market Access & Recent Global Developments
Session: Precision Medicine Beyond Oncology
Integration and Outcomes: Shifting Precision Medicine from the Future to Now
Session: Integrating & Interpreting Personal Genomics, Big Data, & Informatics
Lynn DresslerMission Health
Yasuhiro FunahashiEisai
Patricia GoedeXIFIN
Peter GroenenActelion Pharmaceuticals
Susan HagerFoundation Medicine
Laura HousmanTufts University School of MedicineMolecular Health
Precision Medicine in the Information Age
Session: Precision Medicine Beyond Oncology
Developing a Personalized Medicine Program in a Community Health System: The Mission Health Experience
Leonardo Rodrigues Berg Pharma
David Roth University of Pennsylvania
Mark TrusheimMIT Sloan School of Management
Rina WolfXIFIN
Diane Wuest GNS Healthcare
Precision Medicine
DISTINGUISHED SPEAKERS (cont.)
Session: Incentivizing Precision Medicine: Regulation & Reimbursement
Next-generation Precision Medicine, Are We There Yet?
Implementing Precision Medicine: Diagnosis and Treatment of Lung Cancer
Implementing Precision Medicine, Determining Economic Value Under Adaptive Biomedical Innovation Pathways
Session: Integrating & Interpreting Personal Genomics, Big Data, & Informatics
Session: Precision Medicine Beyond Oncology
Session: Implementation of Precision Medicine: Strategies & Technologies
For an updated speaker list visit: www.gtcbio.com/molecular/speakers
Session: Implementation of Precision Medicine: Strategies & Technologies